Tuesday, September 25, 2012

Barnes & Noble Up Another 4% (BKS, RSH, GOOG, OMEX, VVUS)

Barnes & Noble Inc (NYSE:BKS) climbed up 3.69% to $13.20 on a traded volume of 519k shares. The Company is launching a video streaming and download service for its Nook. The Nook Video service will allow shoppers to buy movies and television shows from Time Warner Inc's HBO; Viacom Inc; Sony Pictures Home Entertainment and Walt Disney Studios.

Will BKS Continue To Move Higher? Find Out Here

RadioShack Corporation (NYSE:RSH) declined 8.82% to $2.79. The Company announced grand openings in Kuala Lumpur for its first two locations in Southeast Asia operated with master franchisee Berjaya RS Sd. Bhd. Berjaya RS Sd. Bhd is a subsidiary of Berjaya Retail Berhad, the Malaysian retailing conglomerate.

Google Inc (NASDAQ:GOOG) soared 1.55% to $760.96. The Company has removed its search engine from mainland China in 2010 due to a dispute over censorship and computer hacking. The Company has decided to shut another of its remaining services in the world’s largest Internet market next month. The service is China music download service.

According to report from Reuters, European Union's antitrust Chief warned Google Inc it could face charges of breaching EU rules and a fine unless it did more to ease concerns it used its search clout to block rivals.

Odyssey Marine Exploration Inc (NASDAQ:OMEX) plunged 19.08% to $2.99 on a traded volume of 2.19 million shares. The Company has received project approval and salvage contracts from ship owners for a major multi-year commodity shipwreck program. The total recovery value of more than $230 million based upon current commodity prices and related assumptions.

How Should Investors Trade OMEX Now? Find Out Here

VIVUS Inc (NASDAQ:VVUS) soared 1.32% to $19.22 on a traded volume of 735k shares. The Company said that European regulators might recommend against approving the Marketing Authorization Application for its blockbuster obesity drug Qsiva. The Company said the disclosure is based on the preliminary feedback from the European Medicines Agency's Committee for Medicinal Products for Human Use.

No comments:

Post a Comment

Privacy Policy | Legal Disclaimer